Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
453 INR | +2.92% | +4.44% | +5.31% |
05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
04-25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.31% | 2.88B | |
+34.35% | 705B | |
+30.94% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.47% | 238B | |
-3.31% | 210B | |
+10.38% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- LAURUSLABS Stock
- News Laurus Labs Limited
- Laurus Labs Completes Acquisition of Additional Stake in Laurus Bio